Diol-functionalized antioxidant and process for preparation thereof
申请人:COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
公开号:US20040192969A1
公开(公告)日:2004-09-30
Diol-functionalized antioxidants and the process for the preparation thereof are disclosed and have the general formula (I):
1
wherein:
R
1
is tert-butyl and R
2
is C
1
to C
8
linear or branched alkyl. The invention also pertains to a process for their preparation.
Which comprises:
Reacting a halo functionalized antioxidant having the general formula (II):
2
wherein:
R
1
is tert-butyl and X is bromide (Br) with a diol having general formula (IV):
3
wherein
R
2
is C
1
to C
8
linear or branched alkyl.
二醇功能化抗氧化剂及其制备方法被披露,并具有通式 (I):
1
其中:
R
1
是叔丁基,R
2
是C
1
至C
8
的直链或支链烷基。 本发明还涉及它们的制备过程。
其包括:
将具有通式 (II) 的卤素功能化抗氧化剂:
2
其中:
R
1
是叔丁基,X 是溴化物 (Br) 与具有通式 (IV) 的二醇反应:
3
其中
R
2
是C
1
至C
8
的直链或支链烷基。
Preparation Method for Amide Compounds and Use Thereof in Medical Field
Provided are a preparation method for amide compounds and use thereof in medical field. Specifically, provided are small molecule amide compounds. Such compounds are inhibitors of enhancer homolog 2 (EZH2) of Zeste gene, and can be used for preventing and/or treating related diseases mediated by EZH2, including tumors, myeloproliferative diseases or autoimmune diseases.
[EN] TRIAZOLYL DERIVATIVES AS SYK INHIBITORS<br/>[FR] DÉRIVÉS TRIAZOLYLE EN TANT QU'INHIBITEURS DE LA SYK
申请人:MERCK SHARP & DOHME
公开号:WO2014048065A1
公开(公告)日:2014-04-03
Provided are triazole derivatives of Formula I which are potent inhibitors of spleen tyrosine kinase and pharmaceutical composition. The triazole derivatives are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.